Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | RNA | QGEN | ||
| Company | Biomarin Pharmaceuticals | Avidity Biosciences Inc | Qiagen N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 57.69 | 72.76 | 49.91 | ||
| High | 58.29 | 72.92 | 53.30 | ||
| Low | 56.87 | 72.64 | 49.37 | ||
| Latest | 57.15 | 72.82 | 51.23 | ||
| Change | -0.47 | +0.10 | -0.48 | ||
| % Change | -0.82% | +0.14% | -0.93% | ||
| Volume | 1,256,800 | 3,461,000 | 5,983,400 | ||
| 20-Day Average Volume | 2,052,980 | 1,741,345 | 3,444,795 | ||
| Previous Close | 57.62 | 72.72 | 51.71 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 56.93 | 72.59 | 51.62 | ||
| 20-Day Raw Stochastic | 42.76% | 71.08% | 43.93% | ||
| 20-Day Relative Strength | 51.18 | 68.99 | 51.75 | ||
| Weighted Alpha | -8.27 | +77.78 | +16.48 | ||
| Today's Opinion | 64% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 64% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 01/29/26 | +0.34% since 01/29/26 | -4.62% since 01/29/26 | ||
| Low | 55.28 on 01/30/26 | 72.40 on 02/02/26 | 49.37 on 02/05/26 | ||
| High | 58.76 on 02/03/26 | 73.06 on 02/03/26 | 53.78 on 01/30/26 | ||
| 1-Month | |||||
| %Chg | -2.92% since 01/05/26 | +1.04% since 01/05/26 | +4.69% since 01/05/26 | ||
| Low | 54.06 on 01/20/26 | 72.03 on 01/06/26 | 46.07 on 01/20/26 | ||
| High | 61.88 on 01/07/26 | 73.06 on 02/03/26 | 57.81 on 01/20/26 | ||
| 3-Month | |||||
| %Chg | +8.24% since 11/05/25 | +4.33% since 11/05/25 | +10.48% since 11/05/25 | ||
| Low | 50.76 on 11/07/25 | 69.67 on 11/07/25 | 45.07 on 11/07/25 | ||
| High | 63.89 on 12/19/25 | 73.06 on 02/03/26 | 57.81 on 01/20/26 | ||
| 6-Month | |||||
| %Chg | -7.72% since 08/05/25 | +90.33% since 08/05/25 | -2.57% since 08/05/25 | ||
| Low | 50.76 on 11/07/25 | 34.90 on 08/06/25 | 45.07 on 11/07/25 | ||
| High | 63.89 on 12/19/25 | 73.06 on 02/03/26 | 57.81 on 01/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,979,315 | 11,268,168 | 10,818,546 | ||
| Shares Outstanding, K | 192,114 | 154,740 | 211,176 | ||
| Annual Sales | 2,853,920,000 | 10,900,000 | 1,978,210,000 | ||
| Annual Net Income | 426,860,000 | -322,300,000 | 83,590,000 | ||
| Last Quarter Sales | 776,130,000 | 12,480,000 | 532,580,000 | ||
| Last Quarter Net Income | -30,740,000 | -174,440,000 | 130,040,000 | ||
| 60-Month Beta | 0.26 | 0.93 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.12 on 10/27/25 | -1.27 on 11/10/25 | 0.62 on 02/04/26 | ||
| Latest Earnings Date | 02/18/26 | 02/26/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | 0.250 on 07/02/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 07/02/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 20.08 | 0.00 | 20.91 | ||